2-aminoethoxydiphenyl borate provides an anti-oxidative effect and mediates cardioprotection during ischemia reperfusion in mice

Hirofumi Morihara, Masanori Obana, Shota Tanaka, Ikki Kawakatsu, Daisuke Tsuchiyama, Shota Mori, Hiroshi Suizu, Akiko Ishida, Rumi Kimura, Izuru Tsuchimochi, Makiko Maeda, Takehiko Yoshimitsu, Yasushi Fujio, Hiroyuki Nakayama

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Excessive levels of reactive oxygen species (ROS) and impaired Ca2+ homeostasis play central roles in the development of multiple cardiac pathologies, including cell death during ischemia-reperfusion (I/R) injury. In several organs, treatment with 2-aminoethoxydiphenyl borate (2-APB) was shown to have protective effects, generally believed to be due to Ca2+ channel inhibition. However, the mechanism of 2-APB-induced cardioprotection has not been fully investigated. Herein we investigated the protective effects of 2-APB treatment against cardiac pathogenesis and deciphered the underlying mechanisms. In neonatal rat cardiomyocytes, treatment with 2-APB was shown to prevent hydrogen peroxide (H2O2) -induced cell death by inhibiting the increase in intracellular Ca2+ levels. However, no 2-APB-sensitive channel blocker inhibited H2O2-induced cell death and a direct reaction between 2-APB and H2O2 was detected by 1H-NMR, suggesting that 2-APB chemically scavenges extracellular ROS and provides cytoprotection. In a mouse I/R model, treatment with 2-APB led to a considerable reduction in the infarct size after I/R, which was accompanied by the reduction in ROS levels and neutrophil infiltration, indicating that the anti-oxidative properties of 2-APB plays an important role in the prevention of I/R injury in vivo as well. Taken together, present results indicate that 2-APB treatment induces cardioprotection and prevents ROS-induced cardiomyocyte death, at least partially, by the direct scavenging of extracellular ROS. Therefore, administration of 2-APB may represent a promising therapeutic strategy for the treatment of ROS-related cardiac pathology including I/R injury.

Original languageEnglish
Article numbere0189948
JournalPLoS One
Volume12
Issue number12
DOIs
Publication statusPublished - Dec 1 2017

Fingerprint

borates
ischemia
Reperfusion
Ischemia
mice
reactive oxygen species
Reactive Oxygen Species
Cell death
Reperfusion Injury
cell death
Cell Death
Pathology
calcium
Cardiac Myocytes
protective effect
2-aminoethoxydiphenyl borate
Cytoprotection
Neutrophil Infiltration
infarction
Scavenging

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Morihara, H., Obana, M., Tanaka, S., Kawakatsu, I., Tsuchiyama, D., Mori, S., ... Nakayama, H. (2017). 2-aminoethoxydiphenyl borate provides an anti-oxidative effect and mediates cardioprotection during ischemia reperfusion in mice. PLoS One, 12(12), [e0189948]. https://doi.org/10.1371/journal.pone.0189948

2-aminoethoxydiphenyl borate provides an anti-oxidative effect and mediates cardioprotection during ischemia reperfusion in mice. / Morihara, Hirofumi; Obana, Masanori; Tanaka, Shota; Kawakatsu, Ikki; Tsuchiyama, Daisuke; Mori, Shota; Suizu, Hiroshi; Ishida, Akiko; Kimura, Rumi; Tsuchimochi, Izuru; Maeda, Makiko; Yoshimitsu, Takehiko; Fujio, Yasushi; Nakayama, Hiroyuki.

In: PLoS One, Vol. 12, No. 12, e0189948, 01.12.2017.

Research output: Contribution to journalArticle

Morihara, H, Obana, M, Tanaka, S, Kawakatsu, I, Tsuchiyama, D, Mori, S, Suizu, H, Ishida, A, Kimura, R, Tsuchimochi, I, Maeda, M, Yoshimitsu, T, Fujio, Y & Nakayama, H 2017, '2-aminoethoxydiphenyl borate provides an anti-oxidative effect and mediates cardioprotection during ischemia reperfusion in mice', PLoS One, vol. 12, no. 12, e0189948. https://doi.org/10.1371/journal.pone.0189948
Morihara, Hirofumi ; Obana, Masanori ; Tanaka, Shota ; Kawakatsu, Ikki ; Tsuchiyama, Daisuke ; Mori, Shota ; Suizu, Hiroshi ; Ishida, Akiko ; Kimura, Rumi ; Tsuchimochi, Izuru ; Maeda, Makiko ; Yoshimitsu, Takehiko ; Fujio, Yasushi ; Nakayama, Hiroyuki. / 2-aminoethoxydiphenyl borate provides an anti-oxidative effect and mediates cardioprotection during ischemia reperfusion in mice. In: PLoS One. 2017 ; Vol. 12, No. 12.
@article{7467abd5f1b341b9b89348a7540a4c91,
title = "2-aminoethoxydiphenyl borate provides an anti-oxidative effect and mediates cardioprotection during ischemia reperfusion in mice",
abstract = "Excessive levels of reactive oxygen species (ROS) and impaired Ca2+ homeostasis play central roles in the development of multiple cardiac pathologies, including cell death during ischemia-reperfusion (I/R) injury. In several organs, treatment with 2-aminoethoxydiphenyl borate (2-APB) was shown to have protective effects, generally believed to be due to Ca2+ channel inhibition. However, the mechanism of 2-APB-induced cardioprotection has not been fully investigated. Herein we investigated the protective effects of 2-APB treatment against cardiac pathogenesis and deciphered the underlying mechanisms. In neonatal rat cardiomyocytes, treatment with 2-APB was shown to prevent hydrogen peroxide (H2O2) -induced cell death by inhibiting the increase in intracellular Ca2+ levels. However, no 2-APB-sensitive channel blocker inhibited H2O2-induced cell death and a direct reaction between 2-APB and H2O2 was detected by 1H-NMR, suggesting that 2-APB chemically scavenges extracellular ROS and provides cytoprotection. In a mouse I/R model, treatment with 2-APB led to a considerable reduction in the infarct size after I/R, which was accompanied by the reduction in ROS levels and neutrophil infiltration, indicating that the anti-oxidative properties of 2-APB plays an important role in the prevention of I/R injury in vivo as well. Taken together, present results indicate that 2-APB treatment induces cardioprotection and prevents ROS-induced cardiomyocyte death, at least partially, by the direct scavenging of extracellular ROS. Therefore, administration of 2-APB may represent a promising therapeutic strategy for the treatment of ROS-related cardiac pathology including I/R injury.",
author = "Hirofumi Morihara and Masanori Obana and Shota Tanaka and Ikki Kawakatsu and Daisuke Tsuchiyama and Shota Mori and Hiroshi Suizu and Akiko Ishida and Rumi Kimura and Izuru Tsuchimochi and Makiko Maeda and Takehiko Yoshimitsu and Yasushi Fujio and Hiroyuki Nakayama",
year = "2017",
month = "12",
day = "1",
doi = "10.1371/journal.pone.0189948",
language = "English",
volume = "12",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "12",

}

TY - JOUR

T1 - 2-aminoethoxydiphenyl borate provides an anti-oxidative effect and mediates cardioprotection during ischemia reperfusion in mice

AU - Morihara, Hirofumi

AU - Obana, Masanori

AU - Tanaka, Shota

AU - Kawakatsu, Ikki

AU - Tsuchiyama, Daisuke

AU - Mori, Shota

AU - Suizu, Hiroshi

AU - Ishida, Akiko

AU - Kimura, Rumi

AU - Tsuchimochi, Izuru

AU - Maeda, Makiko

AU - Yoshimitsu, Takehiko

AU - Fujio, Yasushi

AU - Nakayama, Hiroyuki

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Excessive levels of reactive oxygen species (ROS) and impaired Ca2+ homeostasis play central roles in the development of multiple cardiac pathologies, including cell death during ischemia-reperfusion (I/R) injury. In several organs, treatment with 2-aminoethoxydiphenyl borate (2-APB) was shown to have protective effects, generally believed to be due to Ca2+ channel inhibition. However, the mechanism of 2-APB-induced cardioprotection has not been fully investigated. Herein we investigated the protective effects of 2-APB treatment against cardiac pathogenesis and deciphered the underlying mechanisms. In neonatal rat cardiomyocytes, treatment with 2-APB was shown to prevent hydrogen peroxide (H2O2) -induced cell death by inhibiting the increase in intracellular Ca2+ levels. However, no 2-APB-sensitive channel blocker inhibited H2O2-induced cell death and a direct reaction between 2-APB and H2O2 was detected by 1H-NMR, suggesting that 2-APB chemically scavenges extracellular ROS and provides cytoprotection. In a mouse I/R model, treatment with 2-APB led to a considerable reduction in the infarct size after I/R, which was accompanied by the reduction in ROS levels and neutrophil infiltration, indicating that the anti-oxidative properties of 2-APB plays an important role in the prevention of I/R injury in vivo as well. Taken together, present results indicate that 2-APB treatment induces cardioprotection and prevents ROS-induced cardiomyocyte death, at least partially, by the direct scavenging of extracellular ROS. Therefore, administration of 2-APB may represent a promising therapeutic strategy for the treatment of ROS-related cardiac pathology including I/R injury.

AB - Excessive levels of reactive oxygen species (ROS) and impaired Ca2+ homeostasis play central roles in the development of multiple cardiac pathologies, including cell death during ischemia-reperfusion (I/R) injury. In several organs, treatment with 2-aminoethoxydiphenyl borate (2-APB) was shown to have protective effects, generally believed to be due to Ca2+ channel inhibition. However, the mechanism of 2-APB-induced cardioprotection has not been fully investigated. Herein we investigated the protective effects of 2-APB treatment against cardiac pathogenesis and deciphered the underlying mechanisms. In neonatal rat cardiomyocytes, treatment with 2-APB was shown to prevent hydrogen peroxide (H2O2) -induced cell death by inhibiting the increase in intracellular Ca2+ levels. However, no 2-APB-sensitive channel blocker inhibited H2O2-induced cell death and a direct reaction between 2-APB and H2O2 was detected by 1H-NMR, suggesting that 2-APB chemically scavenges extracellular ROS and provides cytoprotection. In a mouse I/R model, treatment with 2-APB led to a considerable reduction in the infarct size after I/R, which was accompanied by the reduction in ROS levels and neutrophil infiltration, indicating that the anti-oxidative properties of 2-APB plays an important role in the prevention of I/R injury in vivo as well. Taken together, present results indicate that 2-APB treatment induces cardioprotection and prevents ROS-induced cardiomyocyte death, at least partially, by the direct scavenging of extracellular ROS. Therefore, administration of 2-APB may represent a promising therapeutic strategy for the treatment of ROS-related cardiac pathology including I/R injury.

UR - http://www.scopus.com/inward/record.url?scp=85038946367&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038946367&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0189948

DO - 10.1371/journal.pone.0189948

M3 - Article

C2 - 29267336

AN - SCOPUS:85038946367

VL - 12

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 12

M1 - e0189948

ER -